A Study of COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir in the Kingdom of Saudi Arabia
Clinical trial NCT06016556 · COMPLETED
Trial details
- NCT number
- NCT06016556
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-10-17
- Primary completion
- 2024-04-09
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.